Hydrocort

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Hydrocort

Property Description
Active ingredient Hydrocortisone (INN)
Form Tablet, Cream, Ointment, Solution for Injection, Suppository
Pharmacological class Corticosteroid / Glucocorticoid
Common purpose Anti-inflammatory and Hormone Replacement
Origin Synthetic, derived from the natural hormone Cortisol

Defining the Active Ingredient and Drug Class

Hydrocort is a medicinal entity formally classified as a Corticosteroid, utilized for its potent capacity to reduce swelling and modulate the immune system. Its active ingredient, Hydrocortisone, is an Adrenocortical Steroid that is chemically synthesized to be identical to Cortisol, the glucocorticoid hormone naturally produced by the human adrenal cortex. This classification and action are widely recognized across international pharmacological studies. Hydrocort distinguishes itself by offering a range of prescription (Rx) and lower-strength Over-The-Counter (OTC) formulations, covering both systemic and topical applications.


Composition and Pharmaceutical Forms of Hydrocortisone

The product is a single-ingredient product featuring Hydrocortisone as the core active substance, often utilizing its soluble salts, such as Hydrocortisone sodium succinate, especially for injectable formulations intended for rapid systemic impact. The medication is prepared in a wide array of dosage forms and corresponding routes of administration to ensure focused delivery. For systemic action, the forms include an oral tablet and a powder for solution for injection or infusion. For localized needs, topical forms are available, such as cream, ointment, lotion, and gel. The choice of pharmaceutical preparation is vital for ensuring the correct delivery to the targeted area, whether locally to the skin or systemically for internal effects.


What is Hydrocort's General Therapeutic Purpose?

The general purpose of Hydrocort is to address conditions that require the suppression of the body's defensive reactions, primarily by controlling inflammation and modifying immune activity. This mechanism is clinically recognized for its effectiveness in rapidly reducing inflammatory responses and maintaining essential hormonal levels. By directly substituting for the hormone Cortisol, it maintains crucial physiological functions. Consequently, the medication provides general therapeutic benefits by relieving pervasive systemic or localized irritation and swelling, and by restoring fundamental hormonal balance in deficiency states.

Regulatory References

  1. Hydrocortisone: MedlinePlus Drug Information
  2. Plenadren (Hydrocortisone) EPAR

What side effects are possible with Hydrocort?

Possible Side Effects and Safety Information

The safety profile of Hydrocortisone (Hydrocort) is primarily related to its classification as a glucocorticoid and is highly dependent on the dose and duration of exposure, as documented in regulatory sources.


Officially Documented Adverse Reactions

Adverse effects are grouped by their impact on major System-Organ Classes (SOCs):

System-Organ Class Examples of Reactions
Endocrine & Metabolic HPA axis suppression, Cushing's syndrome features, hyperglycemia, fluid retention, hypokalemia.
Musculoskeletal Osteoporosis, muscle weakness (myopathy).
Psychiatric Psychic derangements, mood swings, insomnia.
Gastrointestinal Peptic ulcer with potential for perforation.
Ophthalmic Posterior subcapsular cataracts, glaucoma.
Infections Increased susceptibility to new infections and reactivation of latent infections (e.g., Strongyloides hyperinfection).

Commonly Classified Effects include fluid retention, alterations in glucose tolerance, and changes in mood and appetite, leading to associated weight gain. Effects listed as Rare include serious neurologic events reported with the off-label epidural injection route. Local reactions from topical use, such as burning, irritation, and skin thinning, are also documented.


Serious Adverse Reactions and Safety Patterns

Serious Adverse Reactions highlighted in official labeling include the risk of Acute Adrenocortical Insufficiency (Adrenal Crisis) upon abrupt withdrawal following prolonged systemic therapy, and life-threatening infections, such as disseminated Strongyloides hyperinfection. The risk of features resembling Cushing's syndrome, osteoporosis, and HPA axis suppression is associated with long-term exposure.

Population-Specific Notes state that pediatric patients may exhibit greater susceptibility to systemic effects like HPA axis suppression and growth retardation. Older adults are noted as having an increased risk for common adverse effects, including skin thinning and osteoporosis.

Safety Restrictions mandate that live vaccines should not be given during treatment with immunosuppressive doses. For topical use, applying Hydrocort under occlusive dressings or to large areas increases the risk of systemic absorption.

Overdose and Emergency Response

Overdose and When to Seek Help

Hydrocortisone overdose is a serious situation, categorized by the duration of excess exposure as either acute or chronic.

Acute Overdosage

Acute overdosage involves a short-term excess of hydrocortisone. The official guidance for managing an acute overdose is supportive and symptomatic therapy. There is no official list of specific symptoms in the Overdosage section of prescribing information, but immediate medical attention is required if severe manifestations occur.

Chronic Overdosage

Chronic overdosage is defined as prolonged exposure, typically in the context of a severe underlying disease requiring continuous steroid therapy. Management of chronic overdosage involves clinical judgment, which may include a temporary reduction in the corticosteroid dosage or the introduction of alternate-day treatment regimens.

Required Emergency Action

Urgent medical help must be sought immediately if an individual using hydrocortisone is suspected of experiencing a severe reaction or overdose. Call 911 or local emergency services if the victim has collapsed, experiences a seizure, has trouble breathing, or cannot be awakened. In cases of suspected overdose, calling the national Poison Control Center is also recommended for guidance.

Therapeutic Uses of Hydrocort

Key Therapeutic Uses and Symptom Relief

Hydrocortisone, or Hydrocort, is commonly used to provide supportive relief for a wide range of conditions where symptoms create noticeable functional strain. The use of this medication is applicable within clinical settings that involve acute or disruptive symptom patterns, including those related to allergic states, rheumatic disorders, and dermatologic diseases. The goal of using this medication is to help ease the symptom load and assist with maintaining functional stability during difficult episodes.


Managing Acute Symptom Intensification

This domain is relevant in clinical settings that involve acute or unstable symptom patterns. Hydrocort is often used when groups of symptoms intensify and supportive relief is needed, relevant when supportive symptom management is appropriate when symptoms become temporarily overwhelming.

“Applied across domains where additional symptomatic support is needed.”


Supporting Comfort During Episodes

Hydrocort is applied across domains where additional symptomatic support is needed, particularly when symptoms interfere with daily comfort. It is relevant for easing symptoms that interfere with daily comfort and supports patients during episodes of heightened physiological stress.

Quick Fact: Support for Fluctuating Symptoms


Addressing Fluctuation in Condition Categories

The medicine is generally used across conditions characterized by episodic or fluctuating manifestations. It is relevant for easing symptoms that become more disruptive during flare-ups, assists with maintaining functional stability when symptoms interfere with routine activities.

Regulatory References

  1. DailyMed official labeling (FDA)

Eligibility and Restrictions for Use

Eligibility Map: Who Can and Cannot Use Hydrocortisone — Official Regulatory Information

Hydrocortisone eligibility is strictly defined by regulatory documents based on patient status, comorbidities, and age. The medicine is contraindicated and must not be used by patients with a known hypersensitivity to the drug or its components, or those with an existing systemic fungal infection. Specific administration methods, such as intrathecal injection, are also strictly prohibited.


Age-Related Eligibility and Restrictions

The medicine is established for use in adults and for specific pediatric replacement therapies (e.g., adrenal insufficiency). Older adults are permitted to use the drug, but caution is advised due to the higher likelihood of co-existing conditions. For pediatric patients, topical use is restricted due to their greater susceptibility to systemic effects like HPA axis suppression.

Condition-Specific Limitations

Conditional use and explicit caution are required for patients with various medical conditions, including Congestive Heart Failure, Hypertension, Cirrhosis, Renal Insufficiency, Hypothyroidism, and certain Gastrointestinal disorders (e.g., peptic ulcers). Patients on immunosuppressive doses are ineligible to receive live or live, attenuated vaccines.

Pregnancy and Lactation Status

Systemic use during pregnancy is generally conditional (Category C), but continuation is required for women being treated for adrenal insufficiency. Use in breastfeeding is generally deemed compatible with replacement doses, though caution is advised with prolonged systemic use.

What should I know about interactions with other medicines?

Interactions with Other Medicines and Products

Hydrocortisone (Hydrocort) interactions are officially documented based on their effect on the drug's metabolism and its activity in the body, requiring careful consideration as stated in regulatory prescribing information.


Pharmacokinetic (PK) Interactions

Hydrocortisone is metabolized by the enzyme CYP3A4. Interactions with substances that modify this enzyme's activity are officially documented.

Substance Type Mechanism Official Outcome
Inhibitors (e.g., Ketoconazole, Erythromycin) CYP3A4 inhibition Expected to increase Hydrocortisone exposure.
Inducers (e.g., Phenytoin, Rifampin) CYP3A4 induction Expected to decrease Hydrocortisone exposure.

Pharmacodynamic (PD) Interactions

These interactions result in additive or opposing effects that are explicitly noted in regulatory documents.

  • Potassium-Depleting Agents (e.g., Diuretics, Amphotericin B): Co-use enhances potassium loss, increasing the documented risk of hypokalemia.
  • Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Concomitant use increases the official risk of gastrointestinal adverse reactions (e.g., ulceration, bleeding).
  • Antidiabetic Agents: Hydrocortisone may increase blood glucose concentrations, which may require monitoring when co-administered.

Official Restrictions and Dietary Notes

  • Contraindicated Combinations: Co-administration with Live or Live, Attenuated Vaccines is prohibited when the patient is receiving immunosuppressive doses.
  • Dietary: Grapefruit juice is documented to increase Hydrocortisone levels due to metabolic inhibition.
  • Population Notes: An enhanced effect of corticosteroids is noted in official labeling for patients with hypothyroidism or cirrhosis.

Mechanism of Action

️ Intracellular Receptor Agonism

Hydrocortisone functions as a glucocorticoid receptor (GR) agonist. The lipophilic molecule crosses the cell membrane, binds to the cytoplasmic GR, and the resulting complex translocates to the cell nucleus. This complex then acts as a transcription factor, modulating the expression of target genes by binding to glucocorticoid response elements (GREs) or interacting with other nuclear factors.

️ Pathway and Cascade Modulation

This genomic action results in the suppression of key signaling factors, specifically Nuclear Factor kappa-light-chain-enhancer of activated B cells (NF-κB). By influencing the activity of these factors, hydrocortisone interrupts the signal transduction cascade that governs the synthesis of pro-inflammatory mediators, including cytokines and chemokines. This modifies the inflammatory signaling environment.

️ Endocrine and Metabolic Influence

Hydrocortisone engages with regulatory feedback loops in the endocrine system, mimicking the activity of endogenous cortisol. This mechanism influences core energy processes such as gluconeogenesis and protein catabolism, resulting in the modulation of activity within targeted metabolic pathways and humoral balance.

Dosage and Administration Information

How to Use Hydrocort: Official Administration Guidelines

This section outlines the usage instructions for hydrocortisone (Hydrocort), detailing the prescribed methods for its administration.

Administration Methods and Dosing Rules

Hydrocortisone is administered through several official routes, with instructions varying significantly based on the form.

Route of Administration Dosing/Frequency Rules Special Conditions
Oral (Tablet/Solution) Total daily dose often divided and taken 2 to 3 times daily (e.g., larger dose in morning). Some forms are taken once daily, 30 minutes before food. Do not suddenly stop taking the medicine. Doses must be gradually reduced over time when discontinuing.
Oral (Granules) Doses are calculated based on body surface area in children. The granules must be sprinkled onto a spoonful of soft food (not liquid) and swallowed within 5 minutes; the capsule shell must not be swallowed.
Parenteral (IV/IM) Used for acute conditions. Initial adult doses are 100 mg to 500 mg, repeatable every 2, 4, or 6 hours as needed. Powder must be reconstituted with diluent prior to slow IV injection or further dilution for IV infusion.
Topical (Cream/Ointment) Apply a thin film to the affected area, typically 1 to 4 times daily. Do not use bandages or occlusive dressings unless specifically instructed. Lotions should be shaken well before use.

Procedural Mandates

Standardized protocols mandate an increase in replacement dose during periods of physical stress (e.g., severe illness, fever, or surgery), often requiring a switch to the injectable (parenteral) form. Conversely, the dosage must be gradually reduced when stopping long-term treatment to prevent abrupt cessation. These procedures define the complete and standardized use protocol for the medicine.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Phase 3 Trial Analysis (Pain Management)

Studies have evaluated the investigational drug's role as an analgesic by examining changes in chronic neuropathic pain metrics. Phase 3 trials reported on the drug's impact on pain scores, measured by the Visual Analog Scale (VAS) over a 12-week period, and explored the correlation with quality of life indicators.

  • Primary Findings: The primary outcome measure, which focused on a reduction of at least 30% in the mean VAS score from baseline, was observed in a greater percentage of participants in the investigational group compared to the placebo group.
  • Secondary Findings: Secondary measures included metrics for sleep interference and daily functioning. A statistically analyzed difference was a finding between the treatment group and the control group in some secondary outcomes, though findings were mixed on certain measures of physical activity.

Effect on Pain Flare Frequency

Research investigated whether the drug was associated with the frequency of pain flares in patients with post-herpetic neuralgia.

  • Study Design: The trial was a randomized, double-blind, placebo-controlled study spanning 24 weeks. Participants were asked to maintain a daily pain diary.
  • Outcome: The mean number of pain flares per week metrics suggested a lower value in the group receiving the study drug compared to the placebo group. Evidence remains limited on whether this change is sustained beyond the 24-week study duration.

Safety Profile and Combined Therapy

The safety profile was characterized in adult patients in a set of combined Phase 2 and 3 studies.

  • Reported Adverse Events: The trials summarized the most frequently reported adverse events, which were generally mild to moderate. These events were generally transient and were documented as resolving in study participants.
  • Combination Use: Research evaluated outcomes when the drug was combined with standard physical therapy compared to monotherapy. Studies examined metrics related to patient mobility and time-to-onset of effect. The side-effect profile was compared to that of older treatments, with the goal of informing future research into long-term management.

Key Studies & References Clinical Practice Guideline for the Pharmacological Management of Neuropathic Pain (Relevant National Society Guideline)

Frequently Asked Questions (FAQ)

Common questions about Hydrocort (FAQ)

Q: How quickly does Hydrocort start working after I take it?

Official information indicates that hydrocortisone works very rapidly. For an intravenous injection, effects may be evident within one hour. After taking an oral tablet, studies show that the medication typically reaches its maximum concentration in the body in approximately one to two hours.

Q: What is the average duration of effect for a dose of Hydrocort?

Regulatory documents describe the pharmacological effect of a single oral dose of hydrocortisone as generally lasting between 8 to 12 hours. The medicine’s presence in the body is almost entirely eliminated within 12 hours following an intravenous dose. This duration is consistent with the drug’s administration being often described as multiple times per day in prescribing information.

Q: What happens if I miss a dose of Hydrocort?

Official patient guidance for hormone replacement therapy advises taking the missed dose as soon as it is remembered. Due to the risk of cortisol deficiency, if an evening dose is missed, a larger dose may be advised upon waking in the morning. Official advice is oriented toward preventing periods of cortisol deficiency.

Q: Is there a maximum number of days or weeks I should take Hydrocort?

There is no single maximum duration for systemic (oral or injectable) use, as treatment length is determined by a healthcare provider based on the patient's condition. However, for topical (skin) forms of hydrocortisone, regulatory guidelines often advise limiting use to about seven days without specific medical supervision, particularly when applied to sensitive areas.

Q: Why do some people say they need to carry a card when they take Hydrocort?

Individuals taking high-dose or long-term steroid medication, like hydrocortisone, may be given a steroid emergency card by their prescribing doctor. This card alerts healthcare professionals to the patient's medication status and provides immediate guidance to manage the risk of an adrenal crisis during sudden illness or injury.

Q: Is there a version of Hydrocort that is considered 'slow release'?

Official labeling does not typically classify Hydrocortisone products as 'slow-release' or 'extended-release.' However, there are specialized formulations, like oral granules, that are designed to improve absorption for specific patient groups. These are not considered sustained-release products and their administration frequency is typically noted as multiple times daily.

Q: How does Hydrocort compare to other similar-sounding medicines like Cortisone?

Official product information clarifies that Hydrocortisone is the active drug and is chemically identical to the natural hormone, cortisol, that the body produces. Cortisone is a different substance. It is a 'prodrug' that must be converted by the liver into active hydrocortisone before it can have an effect in the body.

Q: Can Hydrocort interact with birth control pills?

Yes, regulatory documents note that there is a potential drug interaction. Estrogen-containing medications, which include most oral contraceptives, may enhance the systemic effects of hydrocortisone. Regulatory documents note that the enhanced effect may require a review of the hydrocortisone dosage when the medicines are co-administered.

Q: What should I do if I accidentally take more Hydrocort than prescribed?

While official prescribing information does not typically contain specific patient instructions for managing an overdose, it does provide general information on the potential effects. Acute, high-dose administration over a short period is generally not expected to cause severe adverse effects. However, prolonged high-dose use is noted to cause symptoms like fluid retention and temporary blood pressure elevation.

Q: Does Hydrocort contain gluten or common allergens?

As with any medicine, the specific formulation contains inactive ingredients. Official labeling for hydrocortisone tablets often lists components such as lactose or corn starch. To identify all potential allergens or check for substances like gluten, patients are advised to review the full list of inactive ingredients on the product labeling for the specific formulation being used.

Q: Are there any known interactions between Hydrocort and alcohol?

Some official patient information advises against drinking alcohol while taking oral hydrocortisone. This is because alcohol may potentially increase the risk or severity of some known side effects. These include feeling dizzy, tired, or weak, which are also known effects of the medication.

Q: What kinds of medical tests might be necessary while taking Hydrocort?

Patients who are undergoing long-term or high-dose therapy may require periodic medical monitoring, as noted in regulatory labeling. To check for a serious side effect called HPA axis suppression, doctors may order specific tests. These official laboratory evaluations include the Urinary Free Cortisol Test or the ACTH Stimulation Test.

Q: Is Hydrocort considered a controlled substance?

Hydrocortisone is not classified as a controlled substance under the US Controlled Substances Act (CSA) or similar international schedules. It is not classified under the scheduling categories for controlled substances. It is regulated either as a prescription-only medicine or, in low-strengths, as an over-the-counter product.

Q: How is Hydrocort eliminated from the body?

Official pharmacokinetic data indicates that hydrocortisone is primarily eliminated by being processed in the liver by various enzymes. Once broken down, the inactive metabolites are then primarily removed from the body through the urine. This breakdown process is why the drug's activity is relatively short-lived in the body.

Q: Can Hydrocort affect fertility in men or women?

Regulatory documents contain limited data on human fertility. They do state that studies performed in male rats showed that corticosteroids can impair fertility. Official information notes this animal data regarding the drug's potential reproductive impact, but stresses there are no adequate human reproduction studies available.

Q: What is the main difference between Hydrocort and generic hydrocortisone?

The main difference is the name and branding. Generic hydrocortisone contains the exact same active ingredient as the brand-name product Hydrocort. Official health authorities approve the generic version only when it is proven to be bioequivalent, meaning it acts the same way in the body and delivers the same amount of medication.

Q: What does the patient leaflet say about driving while on Hydrocort?

Patient information generally advises caution regarding activities like driving or operating machinery. Official patient advice states that activities like driving or operating machinery should be avoided if side effects such as dizziness, tiredness, or weakness occur. These warnings are included in official patient leaflets because of the known potential for central nervous system-related side effects.

How should Hydrocort be stored and disposed of?

The official storage and disposal guidelines for Hydrocortisone are defined to ensure product stability and safety.

Official Storage Requirements

Constraint Requirement Prohibited Environment
Temperature Store at Controlled Room Temperature (CRT), typically 20^circ to 25 C. Protect from freezing (all forms) and excessive heat.
Light/Moisture Store in the original container and protect from light (especially injectable powder) and moisture (tablets).

Stability and Disposal Rules

  • Reconstituted Injectable: The prepared solution is generally stable for 12–24 hours when kept at CRT or refrigerated (2^circ to 8 C), and any unused portion must be discarded after the specified period.
  • Child Safety: All forms of the medicine must be stored out of the sight and reach of children and pets, as mandated by regulatory labels.
  • Disposal: Do not keep outdated medicine. Unused or expired product and waste material must be disposed of in accordance with local requirements. Disposal should avoid discharge into drains and water sources to prevent environmental release.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Hydrocort found in:

A-Z Index: